최신 시험

EudraCT Number: 2004-000283-27

Sponsor Protocol Number: VX04-765-201

Start Date: 2004-07-19

Sponsor Name: Vertex Pharmaceuticals Incorporated

Full Title: A Pilot Open-Label Study to Investigate the Safety and Anti-inflammatory Effects of VX-765, an Orally Administered Interleukin-1β Converting Enzyme Inhibitor, in Patients with Muckle-Wells Syndrome

Medical condition: Muckle-Wells syndrome

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2004-001205-99

Sponsor Protocol Number: FG-506-02-IT-01

Start Date: 2004-07-19

Sponsor Name: FUJISAWA

Full Title: AN OPEN, MULTICENTRE, RANDOMISED, PARALLEL GROUP STUDY TO COMPARE IN MARGINAL OLD-FOR-OLD RENAL TRANSPLANT PATIENTS THE SAFETY AND EFFICACY OF TWO TREATMENTS: SEQUENTIAL MYCOPHENOLATE MOFETIL / DE...

Medical condition: prevention of rejection of marginal old-for-old renal transplant

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

EudraCT Number: 2004-000015-25

Sponsor Protocol Number: 3066A1-303-WW

Start Date: 2004-07-16

Sponsor Name: Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development

Full Title: A phase 3 randomized, placebo-controlled, double-blind study of oral CCI-779 administered in combination with letrozole vs. letrozole alone as first line hormonal therapy in postmenopausal women wi...

Medical condition: locally advanced or metastatic breast cancer (stage 3B or 4)

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Female

Trial protocol: SK (Completed) LV (Completed) LT (Completed) GB (Completed)

Trial results: View results

EudraCT Number: 2004-000542-20

Sponsor Protocol Number: CLAF237A2338

Start Date: 2004-07-16

Sponsor Name: NOVARTIS FARMA

Full Title: A Multicenter, Double-Blind, Randomized, Active Controlled Study to Compare the Effect of 52 Weeks Treatment with LAF237 50 mg bid to Gliclazide up to 320 mg Daily as Add-On Therapy in Patients wit...

Medical condition: treatment of type 2 diabetes in combination therapy with other anti-diabetic oral drugs

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10018424		HLGT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed) SK (Completed) ES (Completed) DK (Completed) CZ (Completed) HU (Completed) GB (Completed)

Trial results: View results

EudraCT Number: 2004-000306-46

Sponsor Protocol Number: FG-506E-11-03

Start Date: 2004-07-16

Sponsor Name: FUJISAWA

Full Title: A multicentre, 1:1 randomised, double blind, two arm parallel group study to evaluate and compare the efficacy and safety of modified release tacrolimus FK506E (MR4) versus tacrolimus FK506 in comb...

Medical condition: Liver transplantation

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed) FI (Completed) ES (Completed)

Trial results: View results

EudraCT Number: 2004-000390-59

Sponsor Protocol Number: P03802

Start Date: 2004-07-15

Sponsor Name: SCHERING-PLOUGH

Full Title: Safety and efficacy of SCH 417690 in HIV-infected treatment-naive subjects

Medical condition: HIV-1 infected naive subject

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10020161		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Prematurely Ended) GB (Completed)

Trial results: View results

EudraCT Number: 2004-000733-12

Sponsor Protocol Number: SPD476-301

Start Date: 2004-07-14

Sponsor Name: Shire Pharmaceutical Development Inc

Full Title: A phase III, randomized, multi-center, double-blind, parallel-group, placebo controlled study to evaluate the safety and efficacy of SPD476 (mesalazine) given twice daily (2.4g/day) versus SPD476 g...

Medical condition: Subjects who have newly diagnosed or have a diagnosis of relapsing (relapses

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: CZ (Completed)

Trial results: View results

EudraCT Number: 2004-001056-36

Sponsor Protocol Number: Ziprasidona2004

Start Date: 2004-07-14

Sponsor Name: Institut de Recerca

Full Title: Ensayo clínico con Ziprasidona para el tratamiento de la psicopatología no constituyente de un trastorno mental grave en la dependencia del alcohol

Medical condition: Patología psiquiátrica asociada al alcoholismo

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-000345-38

Sponsor Protocol Number: BAP00089

Start Date: 2004-07-13

Sponsor Name: Basilea Pharmaceutica Ltd

Full Title: Efficacy and Safety of BAL4079 in the Treatment of Severe Refractory Chronic Hand Dermatitis

Medical condition: Severe Chronic Hand Dermatitis (CHaD) Refractory to Topical Therapy

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Completed) CZ (Completed) HU (Completed) DK (Completed) GB (Completed)

Trial results: View results

EudraCT Number: 2004-000822-58

Sponsor Protocol Number: C9253

Start Date: 2004-07-13

Sponsor Name: Sanofi-Synthelabo Groupe

Full Title: A double blind randomized study of Clopidogrel 75 mg/d versus placebo on a background of ASA 75-100 mg/d, in peripheral disease (PAD) patient receiving a unilateral below knee by-pass graft.

Medical condition:

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.0		10062585		1

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Completed) FI (Completed) HU (Completed) IT (Completed) GB (Completed) ES (Completed)

Trial results: View results

최신 시험

스폰서 및 공동 작업자

건강 상태

약물 개입